Male Infertility clinical trials

Explore recruiting male infertility clinical trials.

Recruiting male infertility studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Male Infertility trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter Randomized Controlled Trial Assessing the Efficacy and Safety of Recombinant Human Follicle Stimulating Hormone (r-hFSH-alfa originator) and Human Chorionic Gonadotropin (hCG) in Enhancing Sperm Concentration in Men with Oligozoospermia, Low Testosterone, and Normal FSH Serum Levels (APHRODITE Group 3): A Collaborative Research Initiative

Italy, Spain, Germany

Therapeutic use (Phase IV) EU CTIS Study details

NT-NOA - Novel Treatment of some men with Non-Obstructive Azoospermia Et klinisk interventionsforsøg

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

NAPO - Novel Approach for Oligospermia

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

The NOVA-NOA Trial A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of FE 999049 for treatment of men with idiopathic infertility

Spain, Sweden, Denmark, Belgium, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Pharmacodynamics and safety of human recombinant luteinising hormone in hypogonadotropic hypogonadal men

Italy

Phase II and Phase III (Integrated) EU CTIS Study details

Male Infertility trials by city

Male Infertility in Toronto Male Infertility in Vancouver Male Infertility in Montreal Male Infertility in Calgary Male Infertility in Edmonton Male Infertility in Ottawa Male Infertility in Winnipeg Male Infertility in Quebec City Male Infertility in Hamilton Male Infertility in Kitchener Male Infertility in London Male Infertility in Halifax Male Infertility in New York Male Infertility in Los Angeles Male Infertility in Chicago Male Infertility in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease